Shares of Caplin Point Laboratories surged 3.5 percent on January 7 after the US food and drug administration cleared the drugmaker's injectable and ophthalmic manufacturing facility in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback